454 results on '"Campiani, G."'
Search Results
52. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo
53. Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties
54. P.3.d.020 CAM24, a D3/5HT2a/5HT1a ligand reduces psychostimulant induced hyperactivity in mice without causing motor side effects
55. Synthesis and 5-HT Receptors Binding Studies of Some 3-Substituted-2-(4-methyl-1-piperazinyl)-4-phenylquinolines
56. Conformational Flexibility in the Peripheral Site of Torpedo californica Acetylcholinesterase Revealed by the Complex Structure with a Bifunctional Inhibitor
57. X-RAY STRUCTURE OF THE Y702F MUTANT OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-CPW399 AT 2.1 A RESOLUTION.
58. Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents
59. Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors: Synthesis and Biological Evaluation of Novel Quinoxalinylethylpyridylthioureas as Potent Antiviral Agents
60. ChemInform Abstract: Synthesis and Anticholinesterase Activity of Huperzine A Analogues Containing Phenol and Catechol Replacements for the Pyridone Ring.
61. New pyrrolobenzothiazepine derivatives as molecular probes of the ‘peripheral-type’ benzodiazepine receptor (PBR) binding site
62. ChemInform Abstract: Polycondensed Heterocycles. Part 9. Pyrrolo(2,1‐c) (1,4) benzothiazepines. Synthesis of 3‐(Dimethylamino)methyl Derivatives.
63. ChemInform Abstract: An Approach to Modified Heterocyclic Analogues of Huperzine A and Isohuperzine A. Synthesis of the Pyrimidone and Pyrazole Analogues, and Their Anticholinesterase Activity.
64. ChemInform Abstract: Pyrrolo(2,1‐c)(1,4)benzothiazines: Synthesis, Structure‐Activity Relationships, Molecular Modeling Studies, and Cardiovascular Activity.
65. ChemInform Abstract: Synthesis and Acetylcholinesterase Inhibitory Activity of Several Pyrimidone Analogues of Huperzine A.
66. Synthesis and “in vitro” cardiovascular activity of 4-aryl-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,4]benzothiazin-1-ones and 7-acetoxy-6-phenyl-7a,8,9,10-tetrahydropyrrolo [2,1,-d][1,5]benzothiazepin-10-one.
67. Synthesis and preliminary biological evaluation of 1-aminomethyl-4-substituted-4-H-pyrrolo[2,1-C][1,4] benzothiazines, a new class of calcium antagonists.
68. ChemInform Abstract: Polycondensed Heterocycles. Part 8. Synthesis of 11‐Aryl‐5H,11H‐ pyrrolo(2,1‐c)(1,4)benzothiazepines (II) by Pummerer Rearrangement‐ Cyclization Reaction.
69. PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells.
70. Polycondensed Heterocycles. VII. A Convenient Synthesis of Pyrrolo[1,2-a]quinoxaline Derivatives by Intramolecular Aromatic Nucleophilic Displacement
71. ChemInform Abstract: Polycondensed Heterocycles. Part 6. A New Efficient Synthesis of 4H‐ Pyrrolo(2,1‐c)(1,4)benzothiazines.
72. ChemInform Abstract: Polycondensed Heterocycles. Part 4. Synthesis of 1,4‐Dioxo‐2,3,3a,4‐ tetrahydro‐1H‐pyrrolo(2,1‐c)(1,4)benzothiazine.
73. Caspase-activated DNase (CAD)-independent oligonucleosomal DNA fragmentation in chronic myeloid leukaemia cells; a requirement for serine protease and Mn2+-dependent acidic endonuclease activity.
74. Polycondensed Heterocycles.VI. A new efficient synthesis of 4H-pyrrolo [2,1-c][1, 4] Benzothiazines
75. Polycondensed heterocycles. IV. synthesis of 1,4-dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzothiazine
76. Polycondensed heterocycles. IV. synthesis of 1,4-dioxo-2,3,3a,4-tetrahydro-1 H-pyrrolo[2,1- c][1,4]benzothiazine.
77. Polycondensed heterocycles. III. Synthesis of 5,11-dioxo-1,2,3,1 1a-tetrahydro-5 H,11 H- and 5-oxo-2,3,11,1 1a-tetrahydro-1 H,5 H-pyrrolo[2,1- c][1,4]benzothiazepine.
78. Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity
79. Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target
80. Development of Molecular Probes for the Identification of Extra Interaction Sites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE). Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors
81. Novel Atypical Antipsychotic Agents: Rational Design, an Efficient Palladium-Catalyzed Route, and Pharmacological Studies
82. Benzoxepin-Derived Estrogen Receptor Modulators: A Novel Molecular Scaffold for the Estrogen Receptor
83. Pyrrolo[1,3]benzothiazepine-Based Serotonin and Dopamine Receptor Antagonists. Molecular Modeling, Further Structure−Activity Relationship Studies, and Identification of Novel Atypical Antipsychotic Agents
84. Synthesis and Pharmacological Evaluation of Potent and Highly Selective D<INF>3</INF> Receptor Ligands: Inhibition of Cocaine-Seeking Behavior and the Role of Dopamine D<INF>3</INF>/D<INF>2</INF> Receptors
85. Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors
86. Synthesis of New Molecular Probes for Investigation of Steroid Biosynthesis Induced by Selective Interaction with Peripheral Type Benzodiazepine Receptors (PBR)
87. Pyrrolo[1,3]benzothiazepine-Based Atypical Antipsychotic Agents. Synthesis, Structure−Activity Relationship, Molecular Modeling, and Biological Studies
88. Characterization of the 1H-Cyclopentapyrimidine-2,4(1H,3H)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties
89. A Rational Approach to the Design of Selective Substrates and Potent Nontransportable Inhibitors of the Excitatory Amino Acid Transporter EAAC1 (EAAT3). New Glutamate and Aspartate Analogues as Potential Neuroprotective Agents
90. Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent
91. Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase
92. Preparation and biological properties of biotinylated PhTX derivatives
93. Pyrroloquinoxaline Derivatives as High-Affinity and Selective 5-HT<INF>3</INF> Receptor Agonists: Synthesis, Further Structure−Activity Relationships, and Biological Studies
94. Pyrrolobenzoxazepinone Derivatives as Non-Nucleoside HIV-1 RT Inhibitors: Further Structure−Activity Relationship Studies and Identification of More Potent Broad-Spectrum HIV-1 RT Inhibitors with Antiviral Activity
95. Thiazolothiazepine Inhibitors of HIV-1 Integrase
96. Novel and Highly Potent 5-HT<INF>3</INF> Receptor Agonists Based on a Pyrroloquinoxaline Structure
97. Synthesis, Biological Activity, and SARs of Pyrrolobenzoxazepine Derivatives, a New Class of Specific Peripheral-Type Benzodiazepine Receptor Ligands<SUP>1</SUP><BBR RID="jm960251bb00001">
98. Cardiovascular Characterization of Pyrrolo[2,1-d][1,5]benzothiazepine Derivatives Binding Selectively to the Peripheral-Type Benzodiazepine Receptor (PBR): From Dual PBR Affinity and Calcium Antagonist Activity to Novel and Selective Calcium Entry Blockers
99. Pyrrolobenzothiazepinones and Pyrrolobenzoxazepinones: Novel and Specific Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors with Antiviral Activity
100. New Antipsychotic Agents with Serotonin and Dopamine Antagonist Properties Based on a Pyrrolo[2,1-b][1,3]benzothiazepine Structure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.